BACKGROUND: The prognostic factors which can improve the @entity1349 ( @entity1349 ) of @entity1 with T4 @entity356 ( @entity356 ) are still controversial: a meta-analysis was conducted to analyze the impact of clinicopathological parameters on survival after MOR among @entity1 with T4 @entity356 . METHODS: A systematic search was performed. Odd risks (ORs) of @entity1 with T4 @entity356 were used to calculate the relationship between clinicopathological parameters and @entity1349 . RESULTS: Nine studies involving 941 @entity1 with T4 @entity356 were identified. Well-moderate differentiation led to increased 1-, 3-, 5-year @entity1349 with an OR of 2.63, 1.58 and 1.45. Borrmann type I-II led to increased 1-, 3-year @entity1349 with an OR of 1.67 and 2.08. No lymph node @entity3 led to increased 1-, 3-, 5-year @entity1349 with an OR of 7.16, 3.18 and 3.71. Total gastrectomy led to increased 1-, 3-year @entity1349 with an OR of 2.01 and 1.79. >= 2 Organs resected led to increased 1-, 3-year @entity1349 with an OR of 2.19 and 2.19. TNM stage II-III led to increased 1-, 3-year @entity1349 with an OR of 3.68 and 5.75. Curative resection led to increased 1-, 3-, 5-year @entity1349 with an OR of 4.46, 5.80 and 5.98. CONCLUSION: Well-moderate differentiation, Borrmann type I-II, no lymph node @entity3 , total gastrectomy, >= 2 organs resected, TNM stage II-III and curative resection were positive prognostic factors for @entity1349 of @entity1 with T4 @entity356 .

Impact of clinicopathological parameters on survival after multiorgan resection among @entity1 with T4 XXXX : a systematic review and meta-analysis.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric carcinoma', 'GC'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'overall survival']
@entity356 :: (MESH:D013274,Disease) :: ['gastric carcinoma']
